The much-anticipated EU Clinical Trials Regulation aims to lower administrative burdens, streamline processes and increase transparency. While this may make Europe a more attractive destination for clinical research, it also poses significant challenges for the pharma industry.
This article was originally published in European Pharmaceutical Contractor
Attachment
PDF
168.6 kB
Read "EU Clinical Trials Regulation - New and Approved"
